References
- V. A. Saharan, V. Kukkar, M. Kataria, V. Kharb and P. Choudhury, Ordered mixing: mechanism, process and applications in pharmaceutical formulations, Asian J. Pharm. Sci. 3 (2008) 240-259.
- V. A. Saharan, M. Kataria, V. Kukkar, M. Gera and P. K. Choudhury, Dissolution enhancement of drugs Part II: Effect of carriers, Int. J. Health Res. 2 (2009) 207-223.
- V. A. Saharan, M. Kataria, V. Kukkar, M. Gera and P. K. Choudhury, Dissolution enhancement of drugs Part I: Technologies and effect of carriers, Int. J. Health Res. 2 (2009) 107-124.
- C. M. Wassvik, A. G. Holmen, C. A. Bergstrom, I. Zamora and P. Artursson, Contribution of solid-state properties to the aqueous solubility of drugs, Eur. J. Pharm. Sci. 29 (2006) 294-305; DOI: 10.1016/j.ejps.2006.05.013.
- H. Allaboun, K. A. Alkhamis and W. Y. AlMomani, The application of the convective diffusion model and the film equilibrium model to surfactant-facilitated dissolution of gliclazide, Eur. J. Pharm. Sci. 19 (2003) 231-236; DOI: 10.1016/S0928-0987(03)00107-6.
- S. Biswal, J. Sahoo, P. N. Murthy, R. P. Giradkar and J. G. Avari, Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000, AAPS PharmSciTech 9 (2008) 563-570; DOI: 10.1208/s12249-008-9079-z.
- S. Asyarie and H. Rachmawati, In vivo and in vitro evaluation of a solid dispersion system of gliclazide: PEG 6000, PDA J. Pharm. Sci. Technol. 61 (2007) 400-410.
- M. P. Patil and N. J. Gaikwad, Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions, Acta Pharm. 59 (2009) 57-65; DOI: 10.2478/v10007-009-0001-3.
- R. Talari, A. Nokhodchi, S. A. Mostafavi and J. Varshosaz, Dissolution enhancement of gliclazide using pH change approach in the presence of twelve stabilizers with various physico-chemical properties, J. Pharm. Pharm. Sci. 12 (2009) 250-265.
- R. Talari, J. Varshosaz, S. A. Mostafavi and A. Nokhodchi, Gliclazide microcrystals prepared by two methods of in situ micronization: Pharmacokinetic studies in diabetic and normal rats, AAPS PharmSciTech 11 (2010) 786-792; DOI: 10.1208/s12249-010-9441-9.
- M. Barzegar-Jalalia, H. Valizadeha, M.-R. S. Shadbada, K. Adibkiaa, G. Mohammadia, A. Farahania, Z. Arasha and A. Nokhodchi, Cogrinding as an approach to enhance dissolution rate of a poorly water-soluble drug (gliclazide), Powder Technol. 197 (2010) 150-158; DOI: 10.1016/j.powtec.2009.09.008.
- Y. K. Lo, C. J. Chen, T. R. Tsai and T. M. Cham, Comparison of the solubility and dissolution rate between gliclazide solid complex and its nanospheres, Drug Dev. Ind. Pharm. 33 (2007) 301-309; DOI: 10.1080/03639040600920622.
- United States Pharmacopeia XXIV, National Formulary XIX USO Convention, Rockville (MD) 1999.
- P. Costa and J. Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.
- M. Westerberg and C. Nystrom, Physicochemical aspects of drug release. Part 18: Use of a surfactant and a disintegrant for improving drug dissolution rate from ordered mixtures, STPPharm Sci. 3 (1993) 142-147.